MaxCyte announces new CEO, updates revenue guidance
(Sharecast News) - Cell engineering technology specialist MaxCyte announced a significant chief executive transition on Tuesday and updated its revenue guidance for 2023.
Read more(Sharecast News) - Cell engineering technology specialist MaxCyte announced a significant chief executive transition on Tuesday and updated its revenue guidance for 2023.
Read more(Sharecast News) - Cell engineering company MaxCyte announced its membership in the Alliance for mRNA Medicines (AMM) as a founding member on Thursday.
Read more(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
Read moreThursday 2 November | |
BT Group PLC | Half Year Results |
Derwent London PLC | Trading Statement |
Entain PLC | Trading Statement |
Haleon PLC | Q3 Results |
Helios Towers PLC | Q3 Results |
Hikma Pharmaceuticals PLC | Trading Statement |
Howden Joinery Group PLC | Trading Statement |
J Sainsbury PLC | Half Year Results |
Kin & Carta PLC | Full Year Results |
OSB Group PLC | Trading Statement |
Shell PLC | Q3 Results |
Smith & Nephew PLC | Q3 Results |
TI Fluid Systems PLC | Trading Statement |
Trainline PLC | Half Year Results |
Friday 3 November | |
no events scheduled | |
Monday 6 November | |
Kingspan Group PLC | Trading Statement |
Kosmos Energy Ltd | Q3 Results |
Ryanair Holdings PLC | Half Year Results |
Tuesday 7 November | |
Associated British Foods PLC | Full Year Results |
Beazley PLC | Q3 Results |
Direct Line Insurance Group PLC | Trading Statement |
dotdigital Group PLC | Full Year Results |
IWG PLC | Q3 Results |
Persimmon PLC | Trading Statement |
RS Group PLC | Half Year Results |
Vaalco Energy Inc | Q3 Results |
Watches of Switzerland Group PLC | Trading Statement |
Wednesday 8 November | |
Conduit Holdings Ltd | Q3 Results |
ITV PLC | Trading Statement |
JD Wetherspoon PLC | Q1 Results |
Marks & Spencer Group PLC | Half Year Results |
MaxCyte Inc | Q3 Results |
Secure Trust Bank PLC | Trading Statement |
Smiths News PLC | Full Year Results |
Time Out Group PLC | Full Year Results |
Copyright 2023 Alliance News Ltd. All Rights Reserved. |
(Sharecast News) - Cell engineering specialist MaxCyte revised its full-year guidance downwards on Thursday based on its preliminary third-quarter revenue.
Read more(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.
Read more(Alliance News) - MaxCyte Inc on Thursday said it expects revenue in the third quarter and for all of 2023 to fall from a year before, citing volatility in customer activity in the life science tools sector.
Read more(Alliance News) - MaxCyte Inc on Thursday reported an increased loss in the first half of 2023, as revenue fell while costs increased.
Read moreThursday 3 August | |
Helios Towers PLC | Half Year Results |
Hikma Pharmaceuticals PLC | Half Year Results |
Irish Residential Properties REIT PLC | Half Year Results |
London Stock Exchange Group PLC | Half Year Results |
Mears Group PLC | Half Year Results |
Mondi PLC | Half Year Results |
Morgan Sindall Group PLC | Half Year Results |
Next PLC | Trading Statement |
Omega Diagnostics Group PLC | Full Year Results |
Pantheon International PLC | Full Year Results |
Pets At Home Group PLC | Trading Statement |
Rolls-Royce Holdings PLC | Half Year Results |
ScS Group PLC | Trading Statement |
Serco Group PLC | Half Year Results |
Shaftesbury Capital PLC | Half Year Results |
Smith & Nephew PLC | Half Year Results |
Tritax Big Box REIT PLC | Half Year Results |
TT Electronics PLC | Half Year Results |
Walker Crips Group PLC | Full Year Results |
Wizz Air Holdings PLC | Q1 Results |
Friday 4 August | |
Capita PLC | Half Year Results |
Renewables Infrastructure Group Ltd | Half Year Results |
WPP PLC | Half Year Results |
Monday 7 August | |
HydrogenOne Capital Growth PLC | Trading Statement |
Kosmos Energy Ltd | Half Year Results |
PageGroup PLC | Half Year Results |
Tuesday 8 August | |
abrdn PLC | Half Year Results |
Glencore PLC | Half Year Results |
H&T Group PLC | Half Year Results |
InterContinental Hotels Group PLC | Half Year Results |
IWG PLC | Half Year Results |
Quilter PLC | Half Year Results |
Rotork PLC | Half Year Results |
SDI Group PLC | Full Year Results |
SIG PLC | Half Year Results |
TI Fluid Systems PLC | Half Year Results |
Zotefoams PLC | Half Year Results |
Wednesday 9 August | |
4imprint Group PLC | Half Year Results |
Arix Bioscience PLC | Half Year Results |
Bank of Cyprus Holdings PLC | Half Year Results |
Bellway PLC | Trading Statement |
CLS Holdings PLC | Half Year Results |
CML Microsystems PLC | Trading Statement |
Coca-Cola HBC AG | Half Year Results |
Flutter Entertainment PLC | Half Year Results |
Hargreaves Services PLC | Full Year Results |
Hill & Smith PLC | Half Year Results |
Hiscox Ltd | Half Year Results |
MaxCyte Inc | Half Year Results |
Polymetal International PLC | Trading Statement |
RM PLC | Half Year Results |
Secure Trust Bank PLC | Half Year Results |
TP ICAP Group PLC | Half Year Results |
Tui AG | Q3 Results |
Vaalco Energy Inc | Half Year Results |
Copyright 2023 Alliance News Ltd. All Rights Reserved. |
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Read more(Alliance News) - MaxCyte Inc on Monday said it signed a strategic platform licence with Vittoria Biotherapeutics to advance cellular therapies.
Read more(Sharecast News) - MaxCyte announced a strategic platform licence agreement with Vittoria Biotherapeutics on Monday, granting Vittoria non-exclusive clinical and commercial rights to use MaxCyte's 'Flow Electroporation' technology and 'ExPERT' platform.
Read more(Sharecast News) - Cell engineering platform technology company MaxCyte announced a strategic platform licence (SPL) agreement with Lyell Immunopharma - a clinical-stage T-cell reprogramming company - on Thursday.
Read more(Alliance News) - MaxCyte Inc on Thursday said it has signed a strategic platform license with Lyell Immunopharma Inc, a clinical stage T cell reprogramming company.
Read more(Sharecast News) - Cell engineering specialist MaxCyte saw its shares slide on Thursday, after it updated its revenue guidance for the year on the back of its first quarter performance.
Read more